Proliferation during early phases of bronchiolar repair in neonatal rabbits following lung injury by 4-ipomeanol.
Nonciliated bronchiolar (Clara cells) are progenitor cells during development. During differentiation, they are more susceptible to injury by environmental toxicants metabolized by the cytochrome P450 monooxygenase system, and injury results in altered bronchiolar repair and development. Squamous cells and abnormal cuboidal epithelium persist into early adulthood. The hypothesis tested in this study was that the failure of bronchiolar epithelium to repair normally in neonates following injury is due to an inhibition of proliferation. A model of differential repair in rabbit kits was used. Proliferation was followed for 1 week post injury in rabbit kits treated with a single dose of the P450-mediated cytotoxicant 4-ipomeanol (IPO) at 7 days old (repair abnormal) and compared to rabbits treated with a single dose of IPO at 21 days old (repair normal). Proliferation was measured by the nuclear incorporation of 5-chloro-2'-deoxyuridine (CldU) within epithelium at the target site (terminal bronchiole). The repair pattern between the two age groups was histologically defined. There was no difference in the CldU labeling index during the week of repair between the two age groups, even though the bronchiolar epithelium did not return to normal in the animals treated at 7 days old. In summary, proliferation (through S-phase) is not inhibited during repair in neonatal rabbits treated with IPO at 7 days old compared to animals treated at 21 days old, and we conclude that other factors may be responsible for the altered repair in the young neonates injured by a P450-mediated cytotoxicant.
Smiley-Jewell
Suzette M
SM
Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA 95616-8732, USA. smsmiley@ucdavis.edu
Plopper
Charles G
CG
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D000970:Antineoplastic Agents / Q000633:toxicity*; D001980:Bronchi / Q000166:cytology* / Q000187:drug effects; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects; D003857:Deoxyuridine / Q000031:analogs & derivatives* / Q000633:toxicity; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D007150:Immunohistochemistry; D011817:Rabbits; D012038:Regeneration / Q000502:physiology; D013729:Terpenes / Q000633:toxicity*
D000970:Antineoplastic Agents; D013729:Terpenes; C012244:5-chloro-2'-deoxyuridine; C001470:4-ipomeanol; D003857:Deoxyuridine